KMC Speciality Hospitals (India) Ltd
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
- Market Cap ₹ 1,314 Cr.
- Current Price ₹ 80.6
- High / Low ₹ 83.5 / 57.0
- Stock P/E 43.2
- Book Value ₹ 11.2
- Dividend Yield 0.00 %
- ROCE 17.4 %
- ROE 13.9 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 16.9% of last 10 years
Cons
- Stock is trading at 7.21 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | 264 | |
| 30 | 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 174 | 195 | |
| Operating Profit | 2 | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 | 69 |
| OPM % | 5% | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% | 26% |
| 3 | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 4 | |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 9 |
| Depreciation | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 | 20 |
| Profit before tax | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 | 44 |
| Tax % | -81% | -0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% | |
| -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | 30 | |
| EPS in Rs | -0.02 | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 | 1.86 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | 13% |
| 3 Years: | -3% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 32% |
| 5 Years: | 30% |
| 3 Years: | 9% |
| 1 Year: | 4% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -6 | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 | 166 |
| 16 | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | 86 | |
| 7 | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | 31 | |
| Total Liabilities | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 300 |
| 28 | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | 245 | |
| CWIP | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | -0 | -0 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| 5 | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | 55 | |
| Total Assets | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 300 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | |
| -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 | -56 | -51 | |
| -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 | 20 | -2 | |
| Net Cash Flow | 0 | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 | 3 | 4 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 |
| Inventory Days | 48 | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 |
| Days Payable | 187 | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 80 | 153 |
| Cash Conversion Cycle | -129 | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 | -40 | -105 |
| Working Capital Days | -80 | -70 | -60 | -46 | -37 | -28 | -18 | -15 | -27 | -22 | -73 | -22 |
| ROCE % | 2% | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% |
Documents
Announcements
-
Standalone Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025
12 Nov - Q2 and H1 results: Q2 revenue Rs7,490.19L; H1 profit Rs1,837.62L; auditors' limited review unmodified.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 12Th November, 2025
12 Nov - Board approved Q2/H1 30 Sep 2025 results: revenue Rs74.90 crore, H1 profit Rs18.38 crore; auditor reviewed.
-
Board Meeting Intimation for Board Meeting Scheduled To Be Held On 12Th November 2025
7 Nov - Board meeting on 12 Nov 2025 to approve unaudited results for quarter and half-year ended 30 Sep 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Oct - Copy of the certificate dated October 6, 2025, received from our RTA for the quarter ended September 30, 2025.
- Closure of Trading Window 29 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Part of Kauvery Group Hospitals
The company is a super-specialty hospital based in Trichy, belonging to the “Kauvery Hospitals group”. The group has more than 2250 beds of multispecialty hospital chains at 12 locations, providing facilities for 1 lakh per year of IP patients and 10 lakhs per year of OP patients. The group is doing more than 600 transplants, 1000+ Joint Replacements, and 1 lakh + Kidney procedures per year. [1] [2]